Cargando…
Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study
BACKGROUND: Sodium-glucose co-transporter 2 inhibitors (SGLT2 I) has cardiorenal protective properties and are recommended for patients with diabetes and established atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Although cardiorenal complications are high in dia...
Autores principales: | Ng, Ngai Mui, Ng, Yeung Shing, Chu, Tsun Kit, Lau, Phyllis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730654/ https://www.ncbi.nlm.nih.gov/pubmed/36476327 http://dx.doi.org/10.1186/s12875-022-01928-z |
Ejemplares similares
-
Experience of COVID-19 Vaccination among Primary Healthcare Workers in Hong Kong: A Qualitative Study
por: Ng, Kai Man, et al.
Publicado: (2022) -
Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population
por: Yu, Mullin Ho Chung, et al.
Publicado: (2021) -
Thoracic surgery in Hong Kong
por: Chang, Aliss T. C., et al.
Publicado: (2022) -
S2.4a Pythiosis: An emerging disease in Hong Kong
por: Barrs, Fanzcvs Vanessa, et al.
Publicado: (2022) -
Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study
por: Chan, Raymond Ngai Chiu, et al.
Publicado: (2022)